The Impact of Biophoton Therapy on Self-Grown Stem Cells
NCT: NCT06855459 · COMPLETED
Brief Summary
Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.
Frequently Asked Questions
What is The Impact of Biophoton Therapy on Self-Grown Stem Cells?
The Impact of Biophoton Therapy on Self-Grown Stem Cells is a clinical trial registered under NCT06855459. Current status: COMPLETED.
What is the status of NCT06855459?
The current status of NCT06855459 (The Impact of Biophoton Therapy on Self-Grown Stem Cells) is: COMPLETED.
When did The Impact of Biophoton Therapy on Self-Grown Stem Cells start?
The Impact of Biophoton Therapy on Self-Grown Stem Cells started on 2025-02-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.